tiprankstipranks
Trending News
More News >
Telix Pharmaceuticals Ltd. (TLPPF)
OTHER OTC:TLPPF
US Market

Telix Pharmaceuticals (TLPPF) Financial Statements

Compare
172 Followers

Telix Pharmaceuticals Financial Overview

Telix Pharmaceuticals's market cap is currently $2.18B. The company's EPS TTM is $-0.012; its P/E ratio is -322.27; Telix Pharmaceuticals is scheduled to report earnings on February 19, 2026, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 1.25BAU$ 783.21MAU$ 502.55MAU$ 160.10MAU$ 7.60M
Gross ProfitAU$ 662.07MAU$ 509.68MAU$ 314.39MAU$ 29.34MAU$ -29.77M
Operating IncomeAU$ 27.55MAU$ 82.13MAU$ 51.89MAU$ -73.18MAU$ -81.25M
EBITDAAU$ 61.33MAU$ 92.55MAU$ 22.97MAU$ -92.84MAU$ -70.07M
Net IncomeAU$ -11.05MAU$ 49.92MAU$ 5.21MAU$ -104.08MAU$ -80.51M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 212.74MAU$ 710.35MAU$ 123.24MAU$ 116.33MAU$ 22.04M
Total AssetsAU$ 1.77BAU$ 1.52BAU$ 398.30MAU$ 255.35MAU$ 109.81M
Total DebtAU$ 785.24MAU$ 581.45MAU$ 17.45MAU$ 10.45MAU$ 2.54M
Net DebtAU$ 572.50MAU$ -128.90MAU$ -105.79MAU$ -105.88MAU$ -19.50M
Total LiabilitiesAU$ 1.15BAU$ 948.22MAU$ 249.39MAU$ 178.44MAU$ 106.17M
Stockholders' EquityAU$ 622.89MAU$ 568.21MAU$ 148.91MAU$ 80.01MAU$ 2.16M
Cash Flow
Free Cash FlowAU$ -85.62MAU$ 9.00MAU$ 13.09MAU$ -77.83MAU$ -60.67M
Operating Cash FlowAU$ -26.82MAU$ 43.03MAU$ 23.88MAU$ -63.97MAU$ -59.33M
Investing Cash FlowAU$ -443.42MAU$ -135.17MAU$ -25.49MAU$ -17.00MAU$ -2.73M
Financing Cash FlowAU$ -5.77MAU$ 638.92MAU$ 10.19MAU$ 174.96MAU$ 2.85M
Currency in AUD

Telix Pharmaceuticals Earnings and Revenue History

Telix Pharmaceuticals Debt to Assets

Telix Pharmaceuticals Cash Flow

Telix Pharmaceuticals Forecast EPS vs Actual EPS